Scientists announced vaccines for bladder cancer
Scientists announced vaccines for bladder cancer, small-cell lung cancer, and colorectal cancer.
Consensus
- Russian scientists are developing personalized cancer vaccines for bladder, lung, and colorectal cancers.
- The vaccines are tailored to individual patients using their genetic material.
- The development involves AI to accelerate the design process.
- Clinical trials are underway, with some patients already receiving the treatment.
- The vaccines are being developed under the framework of the Russian state healthcare system (OMS).
Points of divergence
- The two types of immunobiological drugs being developed are peptide-based and personalized mRNA vaccines. — vm
- The effectiveness of treatment could increase from 20% to 90% due to AI use. — tg_mash
- The project has been written and approved by the Russian Academy of Sciences and is awaiting funding. — tg_mash
- Each vaccine may require up to 500 laboratory mice for testing. — tg_mash
- Five patients received the colorectal cancer vaccine in May. — komersant
- Therapeutic cancer vaccines are administered only after a disease is present, unlike preventive vaccines. — vm
Coverage (3 sources)
- How the new Russian oncovaccines will work — Вечерняя Москва
- Three new Russian cancer vaccines will be created using AI — a neural network will help convert the patient's genetic information into a vaccine structure and individually select components — Mash
- Ginzburg spoke about plans to develop three new cancer vaccines in Russia — Коммерсантъ
Key entities
- Russia
- RIA Novosti
- RAS
- Gamaleya Research Institute of Epidemiology and Microbiology
- Alexander Ginzburg
- Institute of Experimental Oncology and Biomedical Technologies
- PIMU
- Irina Druzhkova